Medicare & Medicaid
This applies in the 24 states where the vaccine mandate was reinstated by last week's Supreme Court's decision.
Clover saw membership growth in a number of service area counties across Georgia, New Jersey, Pennsylvania and South Carolina.
Arguments center on Aduhelm's price, its questionable clinical benefit and why the agency is going against FDA approval of the drug.
Currently, Aduhelm, made by Biogen, is the only monoclonal antibody approved by the FDA for the treatment of Alzheimer's disease.
Premiums covered the $56,000 yearly cost of the Alzheimer's drug Aduhelm, but that price has been slashed by 50%.
CEO says aggressive pricing from marketplace rivals has played a role in the new projections, shifting the focus to business-wide profitability.
CMS expects the changes to improve beneficiaries' experiences with MA and Part D, calling it a "higher standard" of benefits and health equity.
Aside from COVID-19 tests, spending for all other tests as a group decreased by about $1.2 billion in 2020, a 15.9% dip from 2019.
COVID-19 continued to affect the industry, which has plowed forward with expanded offerings, digital transformation and other bold moves.
The rule establishes DMEPOS fee schedule amounts and procedures for making benefit categories and payment determinations for new items and services.